Consequently, these inhibitors hold promise as a novel treatment for both C9orf72 ALS/FTD and FXTAS, both of which are caused by RAN translation of aberrantly amplified microsatellites [58]. This evidence concerns the gene RAN and amyotrophic lateral sclerosis.